Bbi Research

Koura, a subsidiary of Mexichem Fluor S.A. de C.V. and part of the Orbia community, is a leading provider of advanced fluorine materials for the battery industry. With a focus on improving battery performance, cost, and safety, Koura develops innovative solutions to meet the evolving needs of the global battery supply chain. Through the acquisition of Silatronix, Koura has expanded its technical capabilities in battery materials, offering a range of fluorine-containing products such as electrolyte solutions and custom additives. With a commitment to advancing life around the world, Koura is at the forefront of developing cutting-edge materials for current and next-generation lithium-ion batteries.Generated from the website

Platypus Technologies, based in Fitchburg, WI, is a leading provider of custom solutions for research, product development, and manufacturing. Their services include engineering design, metal coatings, surface patterning, and singulation, empowering scientists to solve a wide range of challenges in fields such as cancer research, drug discovery, quantum computers, and COVID-19 research. With extensive experience in creating biosensors, chemical sensors, microfluidic devices, and more, Platypus Technologies is dedicated to creating innovative surface science-based solutions that drive human progress. They specialize in the deposition of thin films of gold, platinum, silver, aluminum, copper, and nickel, offering unique properties and applications tailored for diverse industrial needs.Generated from the website

Coppe Healthcare Solutions, located in Waukesha, WI, specializes in providing testing and diagnostic services for emerging viral diseases, including Human Herpesvirus-6 (HHV-6) and Powassan Virus. The company serves a diverse clientele of academic medical centers, children's hospitals, and integrative healthcare providers across the nation. With a focus on specialty diagnostics, Coppe Laboratories offers innovative solutions such as self-collection services and custom testing options in infectious disease. Their state-of-the-art BSL-3 facility supports rigorous research and testing to advance the understanding and treatment of viral infections. Generated from the website